Showing results (291-300 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|June 4, 2020
Oncological control following partial gland ablation for intermediate-risk prostate cancerEzequiel Becher, Herbert Lepor
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
Urologic Oncology|June 15, 2020
MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic diseaseMatthew J Moynihan, Travis B Sullivan, Eric Burks, et al.
Urologic Oncology|August 23, 2021
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomyDanijel Sikic, Veronika Weyerer, Carol I Geppert, et al.
Urologic Oncology|May 26, 2020
Examining the association of health literacy and numeracy with prostate-related knowledge and prostate cancer treatment regretDaniel D Joyce, Daniel L Heslop, Jeremiah I Umoh, et al.
Urologic Oncology|May 28, 2020
Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomesHilary L Robertson, Carrie Michel, Lucas Bartl, et al.
Urologic Oncology|August 5, 2021
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survivalAkshay Sood, Jacob Keeley, Isaac Palma-Zamora, et al.
Urologic Oncology|August 16, 2022
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping reviewTiago Costa de Padua, Marco Moschini, Alberto Martini, et al.
Urologic Oncology|May 19, 2021
Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort studyBogomir Milojevic, Zoran Dzamic, Isidora Grozdic Milojevic, et al.
Urologic Oncology|August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomyAlexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
Pageof 487